HPV vaccine protects at multiple sites, even for some previously exposed
نویسندگان
چکیده
منابع مشابه
Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
INTRODUCTION Human papillomavirus (HPV) is one of the most common sexually transmitted infections and is the cause of several different diseases in men and women. Although little is known about HPV infection in men, they are also in the risk group of HPV infection and play an important role in transmitting the virus to women. AIM To define the efficacy of the HPV vaccine through cross-immuniz...
متن کاملQuadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.
A small number of HPV types are related to a majority of HPV-related neoplastic lesions in humans. High-risk types such as HPV 16 and 18 are most often implicated, although other oncogenic and non-oncogenic HPV types can cause disease in men. The efficacy of the quadrivalent HPV vaccine (qHPV) against external genital lesions and intra-anal disease related to HPV in men has been demonstrated. T...
متن کاملAre women ready for the HPV vaccine?
OBJECTIVE An HPV (human papillomavirus) vaccine will be available soon. Because vaccination for both boys and girls will be critical to reduce the incidence of this disease, we evaluated the willingness of women to accept the HPV vaccine and to consent to having their children vaccinated. METHODS A 20-item questionnaire was distributed to women who had children between the ages of 8 and 14 ye...
متن کاملStrategies for Fostering HPV Vaccine Acceptance
Vaccines that protect against infection with the types of human papillomavirus (HPV) commonly associated with cervical cancer (HPV 16 and 18) and genital warts (HPV 6 and 11) are expected to become available in the near future. Because HPV vaccines are prophylactic, they must be administered prior to exposure to the virus, ideally during preadolescence or adolescence. The young age of the targe...
متن کاملHPV vaccine for cancer and wart prevention.
Evidence Three large international RCTs in females aged 15 to 26 used modified intention-to-treat analysis (including patients with positive test results for HPV at baseline) for all HPV lesions.1-4 • Quadrivalent vaccine (HPV 6, 11, 16, and 18): -FUTURE 1 trial1 following 5455 women for 4 years found decreased external genital lesions (3.8% vs 5.7% [placebo]; number needed to vaccinate [NNV] =...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2015
ISSN: 0008-543X
DOI: 10.1002/cncr.29618